Biomet’s Interpore Purchase Creates $200 Mil. Spinal Devices Business
This article was originally published in The Gray Sheet
Executive Summary
Biomet will expand its spinal franchise by nearly one third and gain artificial disc technology via the $280 mil. cash acquisition of Interpore, announced March 8
You may also be interested in...
Biomet Urges Medicare Coding Revision For “Complex” Joint Replacement
CMS should create separate diagnosis-related groups (DRGs) for revision hip and knee surgeries, according to Biomet
Biomet Urges Medicare Coding Revision For “Complex” Joint Replacement
CMS should create separate diagnosis-related groups (DRGs) for revision hip and knee surgeries, according to Biomet
Favorable FDA Panel Reviews Propel Biomet, Cyberonics Stocks In June
Biomet shares climbed 10.8% in June, spurred by completion of a $280 mil. Interpore Cross acquisition and investor confidence in future knee sales growth